ALK alterations and inhibition in lung cancer

Authors

Keywords

Adenocarcinoma, Crizotinib, Oncogene addiction, Personalized medicine, Precision medicine, Targeted therapy

Journal

SEMINARS IN CANCER BIOLOGY

Volume 42, Issue -, Pages 81-88

Publisher

Elsevier BV

Online

2016-09-15

DOI

10.1016/j.semcancer.2016.08.007

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started